Dr. Navid is a Pediatric Oncologist, Professor of Clinical Pediatrics, and Medical Director for Clinical Research for the Cancer and Blood Disease Institute at the Children’s Hospital Los Angeles. Her primary clinical and research interests are in pediatric bone and soft-tissue sarcomas (including desmoid tumors) and early phase drug development for pediatric solid tumors. She is an active member of the Children’s Oncology Group (COG) Soft Tissue Sarcoma and Developmental Therapeutics Committees. Specific to desmoid tumors, Dr. Navid leads the COG phase 2 study of nirogacestat in children and adolescents with unresectable desmoid tumors (ARST1921).
Stay Up to Date as We Uncover More About Desmoid Tumors
Your Donation Changes Lives
Every donation, no matter the size, helps us continue our mission.